Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash from Operations (2016 - 2025)

CorMedix's Cash from Operations history spans 13 years, with the latest figure at 94461181.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 1782.34% year-over-year to 94461181.0; the TTM value through Dec 2025 reached 175046000.0, up 445.84%, while the annual FY2025 figure was 175046000.0, 445.84% up from the prior year.
  • Cash from Operations for Q4 2025 was 94461181.0 at CorMedix, up from 30856502.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 94461181.0 in Q4 2025 and bottomed at 17310294.0 in Q1 2024.
  • The 5-year median for Cash from Operations is 5869360.0 (2021), against an average of 4030891.71.
  • The largest annual shift saw Cash from Operations tumbled 309.81% in 2021 before it soared 1782.34% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 5869360.0 in 2021, then fell by 4.86% to 6154839.0 in 2022, then crashed by 68.87% to 10393886.0 in 2023, then soared by 45.98% to 5614883.0 in 2024, then skyrocketed by 1782.34% to 94461181.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Cash from Operations are 94461181.0 (Q4 2025), 30856502.0 (Q3 2025), and 29991814.0 (Q2 2025).